rs17886395
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBA1
The NM_001098668.4(SFTPA2):āc.271G>Cā(p.Ala91Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.155 in 1,613,720 control chromosomes in the GnomAD database, including 21,037 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in UniProt.
Frequency
Consequence
NM_001098668.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SFTPA2 | ENST00000372325.7 | c.271G>C | p.Ala91Pro | missense_variant | 4/6 | 1 | NM_001098668.4 | ENSP00000361400.2 | ||
SFTPA2 | ENST00000372327.9 | c.271G>C | p.Ala91Pro | missense_variant | 3/5 | 1 | ENSP00000361402.5 | |||
SFTPA2 | ENST00000417041.1 | c.271G>C | p.Ala91Pro | missense_variant | 4/6 | 5 | ENSP00000397375.1 | |||
SFTPA2 | ENST00000492049.1 | c.271G>C | p.Ala91Pro | missense_variant | 2/2 | 5 | ENSP00000473275.1 |
Frequencies
GnomAD3 genomes AF: 0.167 AC: 25407AN: 151868Hom.: 2350 Cov.: 32
GnomAD3 exomes AF: 0.189 AC: 47412AN: 251402Hom.: 5077 AF XY: 0.188 AC XY: 25500AN XY: 135884
GnomAD4 exome AF: 0.153 AC: 223882AN: 1461732Hom.: 18674 Cov.: 70 AF XY: 0.156 AC XY: 113246AN XY: 727174
GnomAD4 genome AF: 0.168 AC: 25474AN: 151988Hom.: 2363 Cov.: 32 AF XY: 0.172 AC XY: 12745AN XY: 74306
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2018 | This variant is associated with the following publications: (PMID: 16292672, 20466729) - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 26, 2014 | p.Ala91Pro in exon 4 of SFTPA2: This variant is not expected to have clinical si gnificance because it has been identified in 14.3% (1226/8592) of European Ameri can chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington. edu/EVS/; dbSNP rs17886395). - |
SFTPA2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 29, 2021 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at